The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Rheumatology Research Foundation’s Campaign to Advance Patient Care Ahead of Schedule

Rheumatology Research Foundation’s Campaign to Advance Patient Care Ahead of Schedule

June 1, 2014 • By Staff

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Some of the most significant support has come from the Corporate Roundtable, a dynamic partnership between the Foundation and industry leaders that provides a forum for dialogue. As part of the Corporate Roundtable and a Leadership level donor, AbbVie has been a major supporter of the Foundation for several years. The company’s generous contributions to the campaign have helped push the fundraising ahead of schedule.

You Might Also Like
  • Rheumatology Research Foundation Fundraising Campaign Exceeds $60M Goal
  • Rheumatology Research Foundation Reaches $60 Million Journey to Cure Goal
  • Rheumatology Research Foundation’s Partnership with CRT Allows for Investment in Research, Training
Explore This Issue
June 2014
Also By This Author
  • Healthcare Market Payment Shift Makes Patient Co-Pays More Important

The Journey to Cure campaign has been quite a success so far. … Some of the most significant support has come from the Corporate Roundtable, a dynamic partnership between the Foundation & industry leaders.

“We are proud to support the Rheumatology Research Foundation’s Journey to Cure initiative, which continues to foster ongoing education and innovative research within the rheumatology community,” says Jim Salanty, vice president, U.S. Rheumatology, AbbVie. “At AbbVie, in our ongoing rheumatology work, we share a passion for creating meaningful options for those living with rheumatic diseases and working in the field of rheumatology, and our relationship with the Foundation is a natural extension of this commitment.”

Another Leadership level donor, Amgen Inc., has made significant contributions to the success of the Journey to Cure campaign. Amgen was actually the first Leadership level donor on the Corporate Roundtable and continues to support the Foundation’s efforts to advance treatments and find cures. “Amgen is proud of its ongoing commitment to support the Journey to Cure campaign, including for the fellowship program, which helps ensure we have well-trained researchers working in the field to advance our understanding and treatment of rheumatic diseases,” says Brian Kotzin, MD, vice president of global development at Amgen. “This initiative helps to reinforce Amgen’s commitment to advancing rheumatology care for the benefit of patients worldwide.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Other companies on the Corporate Roundtable are also taking part in Journey to Cure. Pfizer Inc., a Pinnacle level donor, has committed substantial financial support to the campaign. These groups are essential to discovering advancements in treating rheumatic diseases.

Patients and loved ones of individuals affected by rheumatic disease are also making significant commitments to Journey to Cure.

To them, supporting the Foundation and the campaign is also a way to invest in their own futures and the futures of others like themselves.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

“As a patient, I want to see research into cures for rheumatic disease,” explains Bedford Vestal. “As a retired scientist, I know how hard it is for new researchers to acquire research funds to get their first projects started and prove themselves. We donate to support both these goals.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 | Single Page

Filed Under: From the College Tagged With: AC&R, American College of Rheumatology, Association of Rheumatology Professionals (ARP), Education, Journey to Cure, patient care, Research, rheumatologist, Rheumatology Research FoundationIssue: June 2014

You Might Also Like:
  • Rheumatology Research Foundation Fundraising Campaign Exceeds $60M Goal
  • Rheumatology Research Foundation Reaches $60 Million Journey to Cure Goal
  • Rheumatology Research Foundation’s Partnership with CRT Allows for Investment in Research, Training
  • Rheumatology Research Foundation Announces 2015 Grants and Awards

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.